Disease | hemophagocytic lymphohistiocytosis |
Comorbidity | C0024314|lymphoproliferative disorder |
Sentences | 1 |
PubMedID- 24169729 | The emergence of cd20-/cd19- tumor cells after rituximab therapy for epstein-barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis. |
Page: 1